ConductScience.org, home

Paper16633338

VEGF receptor signalling - in control of vascular function.

Olsson AK and 3 others. Nat Rev Mol Cell Biol, 2006. Cited by 2,573 papers, by iCite.

Cite this record

ConductScience Library. VEGF receptor signalling - in control of vascular function. Papers, record 16633338. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16633338

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
VEGF receptor signalling - in control of vascular function.
PubMed
Journal
Nat Rev Mol Cell Biol
PubMed
Year
2006
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
2,573
iCite
Relative citation ratio, by iCite
59
iCite
Revised in PubMed
2023-07-18
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Olsson AKAnna-Karin
2Dimberg AAnna
3Kreuger JJohan
4Claesson-Welsh LLena

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Neovascularization, PhysiologicMajor topic
Receptors, Vascular Endothelial Growth FactorMajor topic
Signal TransductionMajor topic
Animals
Embryonic Development
Humans
Stem Cells
Vascular Endothelial Growth Factors

Source PubMed

Download CSV of topics

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT03219398The Effect of Lower Intraabdominal Pressure on Syndecan-1, sVEGF-R2, Occludin, KIM-1, and IL-6 on Living Donor Laparoscopic NephrectomyBackgroundClinicalTrials.gov
NCT03883412Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)BackgroundClinicalTrials.gov
NCT04575844Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic SyndromeBackgroundClinicalTrials.gov

Download CSV of trials

Cited by1,458

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,573 citations.

PMIDTitleJournalYearIn PapersSource
42942141VEGF Signaling and Targeted Therapies in Cancer: Molecular Mechanisms, Clinical Applications, Resistance, and Cardiorenal Toxicities.Int J Mol Sci2026https://conductscience.org/library/papers/42942141PubMed
42903656Graphene oxide-induced multiple iPSC spheroid formation for enhanced production of angiogenic exosomes accelerating tissue regeneration.Mater Today Bio2026https://conductscience.org/library/papers/42903656PubMed
42889244Targeting vascular endothelial growth factor (VEGF)-induced angiogenesis with Rosa hybrida leaf extract via VEGF receptor-2 signaling and matrix metalloproteinase-2 inhibition.Nutr Res Pract2026https://conductscience.org/library/papers/42889244PubMed
42836994VEGF pathway signalling across pulmonary neuroendocrine tumours: associations with histological subtypes in a multicentre study.Virchows Arch2026https://conductscience.org/library/papers/42836994PubMed
42829897VEGF165b attenuates LPS-induced acute lung injury via antagonizing the VEGF165a/VEGFR2 signaling pathway.Angiogenesis2026https://conductscience.org/library/papers/42829897PubMed
42796425Polydeoxyribonucleotide Enhances Liver Regeneration Following Partial Hepatectomy in Rats in Association with Growth Factor and A2A Receptor Signaling.Medicina (Kaunas)2026https://conductscience.org/library/papers/42796425PubMed
42764959Deconvoluting the multi-faceted roles of alternative splicing events in cancer: From underlying mechanisms to innovative therapeutics.Acta Pharm Sin B2026https://conductscience.org/library/papers/42764959PubMed
42762961Receptor tyrosine kinase signaling in mammalian eye development.Dev Biol2026https://conductscience.org/library/papers/42762961PubMed
42751636Five VEGFA Polymorphisms and Bleeding During Warfarin Therapy in a Saudi Population: An Exploratory Retrospective Cohort Study.Pharmgenomics Pers Med2026https://conductscience.org/library/papers/42751636PubMed
42747637Homocysteine and mitophagy in diabetic retinopathy: unraveling the underlying molecular crosstalk.Endocrine2026https://conductscience.org/library/papers/42747637PubMed
42737738Research Progress on Angiogenesis and Involution Mechanisms of Infantile Hemangioma and Its Regulation by Active Components of Salvia miltiorrhiza.Int J Mol Sci2026https://conductscience.org/library/papers/42737738PubMed
42726186Remote periosteal distraction promotes ischemic diabetic foot wound repair associated with VEGF/VEGFR2-related angiogenic responses.J Mol Histol2026https://conductscience.org/library/papers/42726186PubMed
42717534Structural Basis of Lymphangiogenic Receptor VEGFR-3 Activation Mediated by Distinctive Clustering of the Ligand-Receptor Complex.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42717534PubMed
42652176Glycation at the Gate: A Brain Endothelial Glycocalyx Model and Therapeutic Roadmap for Alzheimer's Disease.Biomedicines2026https://conductscience.org/library/papers/42652176PubMed
42592693Discovery of VEGFR-2 Inhibitors From Leonurus japonicus via Integrated Genetic Authentication, Molecular Networking, and In Silico Analysis.Arch Pharm (Weinheim)2026https://conductscience.org/library/papers/42592693PubMed
42584757Succinic Acid-Sunitinib Combination Treatment Downregulates the Angiogenic Gene Expressions in Sunitinib- Resistant Renal Cancer Cell Line.Cell Biochem Biophys2026https://conductscience.org/library/papers/42584757PubMed
42571573Engineering functional vasculatures to reconstruct sympathetic-parasympathetic circuits for bladder function after spinal cord injury.Bioact Mater2027https://conductscience.org/library/papers/42571573PubMed
42538573CEUS with VEGFR2-targeted microbubbles for monitoring of early immunotherapy effects in a colorectal cancer model.Cancer Imaging2026https://conductscience.org/library/papers/42538573PubMed
42510843Transcriptomic Signatures of Exercise-Modality Responses in Aged Human Skeletal Muscle.Genes (Basel)2026https://conductscience.org/library/papers/42510843PubMed
42509338CLK3 regulates tumor angiogenesis by modulating HIF1α ubiquitination.Cancer Gene Ther2026https://conductscience.org/library/papers/42509338PubMed

See all 1,458 cited byDownload CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16633338

GET https://conductscience.org/api/papers/v1/16633338/cited_by?page=2